Search Results

Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults-a nationwide registry-based study

by Gudbjornsson, Bjorn, Thorsteinsson, Sigurdur B, Sigvaldason, Helgi, Einarsdottir, Rannveig, Johannsson, Magnus, Zoega, Helga, Halldorsson, Matthias, Thorgeirsson, Gudmundur
Published in European Journal of Clinical Pharmacology (2011)